Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4743.TWO Stock Summary
Top 10 Correlated ETFs
4743.TWO
In the News
4743.TWO Financial details
Company Rating
Buy
Market Cap
93.62B
Income
-305.52M
Revenue
1.07B
Book val./share
37.33
Cash/share
21
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
09 Aug 2023
P/E
-297.48
Forward P/E
-
PEG
107.09
P/S
85.49
P/B
6.25
P/C
11.12
P/FCF
-88.78
Quick Ratio
40.96
Current Ratio
42.03
Debt / Equity
0.05
LT Debt / Equity
0.02
-
-
EPS (TTM)
-0.78
EPS next Y
-
EPS next Q
-
EPS this Y
-187.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
124.09%
Revenue Q/Q
50.16%
EPS Q/Q
-58.68%
-
-
-
-
SMA20
-3.32%
SMA50
-10.04%
SMA100
-7.54%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-2%
ROC
-0.01%
Gross Margin
79%
Oper. Margin
-19%
Profit Margin
-29%
Payout
-
Shs Outstand
390.91M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
155.5-309.5
52W High
-24.43%
52W Low
+50.65%
RSI
50
Rel Volume
0.52
Avg Volume
4.44M
Volume
2.3M
Perf Week
4.71%
Perf Month
-2.51%
Perf Quarter
-
Perf Half Y
-21.38%
-
-
-
-
Beta
1.68835
-
-
Volatility
4.43%, 8.24%
Prev Close
-2.71%
Price
233.5
Change
-3.11%
4743.TWO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.1 | 0.05 | 0.12 | 0.17 | 2.8 | |
Net income per share | -1.2 | -1.28 | -0.71 | -1.08 | 0.95 | |
Operating cash flow per share | -0.03 | -0.85 | 0.44 | -0.76 | -2.32 | |
Free cash flow per share | -0.88 | -1.04 | 0.01 | -1.02 | -2.55 | |
Cash per share | 3.21 | 6.32 | 23.31 | 20.48 | 21.15 | |
Book value per share | 10.37 | 25.19 | 38.2 | 36.77 | 38.42 | |
Tangible book value per share | 11.06 | 15.56 | 31.38 | 30.46 | 33.59 | |
Share holders equity per share | 10.37 | 25.19 | 38.2 | 36.77 | 38.42 | |
Interest debt per share | 0 | 1.33 | 0.86 | 0.76 | 0.7 | |
Market cap | 5.21B | 7.38B | 86B | 109.59B | 93.41B | |
Enterprise value | 5.06B | 7.55B | 86.09B | 109.54B | 88.01B | |
P/E ratio | -22.12 | -22.92 | -341.72 | -265.47 | 259.48 | |
Price to sales ratio | 276.15 | 547.96 | 2.07K | 1.67K | 87.66 | |
POCF ratio | -1.02K | -34.62 | 543.85 | -379.35 | -106.02 | |
PFCF ratio | -30.21 | -28.34 | 17.67K | -281.59 | -96.28 | |
P/B Ratio | 2.57 | 1.17 | 6.31 | 7.82 | 6.39 | |
PTB ratio | 2.57 | 1.17 | 6.31 | 7.82 | 6.39 | |
EV to sales | 268.16 | 559.99 | 2.07K | 1.67K | 82.6 | |
Enterprise value over EBITDA | -22.59 | -29.72 | -1.65K | -565.48 | 92.56 | |
EV to operating cash flow | -987 | -35.38 | 544.39 | -379.18 | -99.9 | |
EV to free cash flow | -29.33 | -28.96 | 17.69K | -281.47 | -90.72 | |
Earnings yield | -0.05 | -0.04 | 0 | 0 | 0 | |
Free cash flow yield | -0.03 | -0.04 | 0 | 0 | -0.01 | |
Debt to equity | 0.08 | 0.08 | 0.12 | 0.12 | 0.05 | |
Debt to assets | 0.07 | 0.07 | 0.11 | 0.1 | 0.04 | |
Net debt to EBITDA | 0.67 | -0.64 | -1.64 | 0.25 | -5.67 | |
Current ratio | 31.83 | 23.5 | 58.15 | 51.21 | 39.47 | |
Interest coverage | -22.03K | -51.14 | -47.27 | -79.83 | 99.29 | |
Income quality | 0.02 | 0.65 | -0.63 | 0.73 | -1.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.41 | 5.11 | 2.57 | 1.43 | 0.11 | |
Research and developement to revenue | 5.01 | 17.71 | 14.16 | 12.26 | 0.86 | |
Intangibles to total assets | 0 | 0.37 | 0.17 | 0.16 | 0.13 | |
Capex to operating cash flow | 32.65 | 0.22 | -0.97 | 0.35 | 0.1 | |
Capex to revenue | -8.87 | -3.51 | -3.68 | -1.53 | -0.08 | |
Capex to depreciation | -14.36 | -0.71 | -0.8 | -0.51 | -0.18 | |
Stock based compensation to revenue | 0.22 | 1.66 | 0.77 | 0.33 | 0.02 | |
Graham number | 16.75 | 26.97 | 24.62 | 29.93 | 28.6 | |
ROIC | -0.06 | -0.05 | -0.02 | -0.03 | 0.08 | |
Return on tangible assets | -0.1 | -0.07 | -0.02 | -0.03 | 0.03 | |
Graham Net | 2.47 | 4.35 | 18.83 | 16.3 | 19.46 | |
Working capital | 721.76M | 1.62B | 8.78B | 7.89B | 8.02B | |
Tangible asset value | 2.17B | 3.91B | 11.2B | 11.61B | 12.78B | |
Net current asset value | 575.53M | 1.17B | 7.31B | 6.41B | 7.53B | |
Invested capital | 0 | 0.05 | 0.02 | 0.02 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 259K | 377.5K | 24.37M | 25.09M | 1.58M | |
Average inventory | 45.55M | 49.36M | 52.75M | 77.39M | 105.83M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 15.98 | 6.61 | 1.62K | 30.72 | 2.33 | |
Days of inventory on hand | 1.8K | 1.04K | 1.92K | 1.72K | 188.2 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 22.84 | 55.2 | 0.22 | 11.88 | 156.63 | |
Inventory turnover | 0.2 | 0.35 | 0.19 | 0.21 | 1.94 | |
ROE | -0.12 | -0.05 | -0.02 | -0.03 | 0.02 | |
Capex per share | -0.85 | -0.19 | -0.43 | -0.26 | -0.23 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.05 | 2.61 | 0.04 | 0.04 | 0.06 | |
Net income per share | 1.01 | 0.87 | 0.71 | -1.67 | -0.69 | |
Operating cash flow per share | -0.34 | -0.51 | -0.45 | -0.98 | -0.5 | |
Free cash flow per share | -0.4 | -0.56 | -0.46 | -1.08 | -0.55 | |
Cash per share | 19.84 | 19.5 | 21.8 | 20.73 | 21 | |
Book value per share | 36.77 | 36.88 | 39.59 | 37.65 | 37.33 | |
Tangible book value per share | 30.59 | 31.33 | 34.64 | 32.92 | 33.29 | |
Share holders equity per share | 36.77 | 36.88 | 39.59 | 37.65 | 37.33 | |
Interest debt per share | 0.72 | 0.68 | 0.68 | 0.68 | 0.67 | |
Market cap | 82.81B | 68.28B | 98.03B | 95.31B | 103.93B | |
Enterprise value | 82.84B | 68.38B | 97.69B | 89.92B | 103.33B | |
P/E ratio | 53.28 | 50.43 | 88.91 | -36.64 | -96.45 | |
Price to sales ratio | 4.12K | 67.15 | 7.08K | 6.45K | 4.68K | |
POCF ratio | -634.36 | -345.16 | -563.27 | -251.74 | -537.01 | |
PFCF ratio | -532.5 | -312.52 | -550.39 | -227.97 | -486.95 | |
P/B Ratio | 5.83 | 4.76 | 6.38 | 6.52 | 7.15 | |
PTB ratio | 5.83 | 4.76 | 6.38 | 6.52 | 7.15 | |
EV to sales | 4.12K | 67.25 | 7.05K | 6.09K | 4.66K | |
Enterprise value over EBITDA | 188.27 | 103.58 | 254.23 | -168.52 | -659.77 | |
EV to operating cash flow | -634.59 | -345.66 | -561.35 | -237.5 | -533.93 | |
EV to free cash flow | -532.69 | -312.97 | -548.52 | -215.07 | -484.15 | |
Earnings yield | 0 | 0 | 0 | -0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.12 | 0.04 | 0.04 | 0.05 | 0.05 | |
Debt to assets | 0.1 | 0.04 | 0.04 | 0.04 | 0.04 | |
Net debt to EBITDA | 0.07 | 0.15 | -0.87 | 10.1 | 3.81 | |
Current ratio | 44.71 | 44.57 | 45.09 | 39.47 | 42.03 | |
Interest coverage | 334.33 | 376.66 | 245.64 | -571.01 | -237.6 | |
Income quality | -0.33 | -0.46 | -0.63 | 0.58 | 0.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.43 | 0.03 | 2.51 | 1.48 | 1.64 | |
Research and developement to revenue | 9.54 | 0.2 | 18.86 | 17.77 | 9.59 | |
Intangibles to total assets | 0.15 | 0.15 | 0.13 | 0.13 | 0.13 | |
Capex to operating cash flow | 0.19 | 0.1 | 0.02 | 0.1 | 0.1 | |
Capex to revenue | -1.24 | -0.02 | -0.29 | -2.67 | -0.9 | |
Capex to depreciation | -0.51 | -0.09 | -0.04 | -0.34 | -0.18 | |
Stock based compensation to revenue | 0.19 | 0 | 0.51 | 0.38 | 0.36 | |
Graham number | 28.86 | 26.87 | 25.15 | 37.67 | 24.11 | |
ROIC | 0.03 | 0.02 | 0.02 | -0.15 | -0.02 | |
Return on tangible assets | 0.03 | 0.03 | 0.02 | -0.05 | -0.02 | |
Graham Net | 15.67 | 18.01 | 20.28 | 19.07 | 19.39 | |
Working capital | 7.73B | 7.56B | 8.44B | 8.02B | 8.19B | |
Tangible asset value | 11.81B | 12.19B | 13.45B | 12.78B | 12.96B | |
Net current asset value | 6.25B | 7.1B | 7.98B | 7.53B | 7.7B | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.21M | 657K | 751K | 1.14M | 2.16M | |
Average inventory | 96.87M | 96.39M | 104.56M | 113.24M | 117.99M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 4.61 | 0.3 | 8.79 | 11.47 | 22.58 | |
Days of inventory on hand | 648.52 | 46.33 | 1.13K | 926.08 | 949.59 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 19.53 | 297.65 | 10.24 | 7.85 | 3.99 | |
Inventory turnover | 0.14 | 1.94 | 0.08 | 0.1 | 0.09 | |
ROE | 0.03 | 0.02 | 0.02 | -0.04 | -0.02 | |
Capex per share | -0.06 | -0.05 | -0.01 | -0.1 | -0.05 |
4743.TWO Frequently Asked Questions
What is Oneness Biotech Co., Ltd. stock symbol ?
Oneness Biotech Co., Ltd. is a TW stock and trading under the symbol 4743.TWO
What is Oneness Biotech Co., Ltd. stock quote today ?
Oneness Biotech Co., Ltd. stock price is $233.5 today.
Is Oneness Biotech Co., Ltd. stock public?
Yes, Oneness Biotech Co., Ltd. is a publicly traded company.